Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease.
Mesenchymal stem cell (MSC) therapy has shown promise clinically in graft-versus-host disease and in preclinical animal models of T helper type 1 (Th1)-driven autoimmune diseases, but whether MSCs can be used to treat autoimmune disease in general is unclear. Here, the therapeutic potential of MSCs was tested in the New Zealand black (NZB)xNew Zealand white (NZW) F1 (NZB/W) lupus mouse model. The pathogenesis of systemic lupus erythematosus involves abnormal B and T cell activation leading to autoantibody formation. To test whether the immunomodulatory activity of MSCs would inhibit the development of autoimmune responses and provide a therapeutic benefit, NZB/W mice were treated with Balb/c-derived allogeneic MSCs starting before or after disease onset. Systemic MSC administration worsened disease and enhanced anti-double-stranded DNA (dsDNA) autoantibody production. The increase in autoantibody titres was accompanied by an increase in plasma cells in the bone marrow, an increase in glomerular immune complex deposition, more severe kidney pathology, and greater proteinuria. Co-culturing MSCs with plasma cells purified from NZB/W mice led to an increase in immunoglobulin G antibody production, suggesting that MSCs might be augmenting plasma cell survival and function in MSC-treated animals. Our results suggest that MSC therapy may not be beneficial in Th2-type T cell- and B cell-driven diseases such as lupus and highlight the need to understand further the appropriate application of MSC therapy.
Youd
M
M
Stem Cell Biology, Genzyme Corporation, Framingham, MA 01701, USA. michele.youd@genzyme.com
Blickarz
C
C
Woodworth
L
L
Touzjian
T
T
Edling
A
A
Tedstone
J
J
Ruzek
M
M
Tubo
R
R
Kaplan
J
J
Lodie
T
T
D000818:Animals; D000974:Antibodies, Antinuclear / Q000096:biosynthesis / Q000276:immunology; D000936:Antigen-Antibody Complex / Q000032:analysis; D001324:Autoantigens / Q000276:immunology; D001853:Bone Marrow / Q000473:pathology; D002478:Cells, Cultured / Q000637:transplantation; D003433:Crosses, Genetic; D016207:Cytokines / Q000032:analysis; D004247:DNA / Q000276:immunology; D005260:Female; D007678:Kidney Glomerulus / Q000276:immunology / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000235:genetics / Q000276:immunology / Q000517:prevention & control*; D008181:Lupus Nephritis / Q000209:etiology / Q000473:pathology; D008213:Lymphocyte Activation; D008297:Male; D045164:Mesenchymal Stem Cell Transplantation / Q000009:adverse effects; D051379:Mice; D008807:Mice, Inbred BALB C; D008814:Mice, Inbred NZB; D008815:Mice, Inbred Strains; D010950:Plasma Cells / Q000473:pathology; D011507:Proteinuria / Q000209:etiology / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology; D014184:Transplantation, Homologous
D000974:Antibodies, Antinuclear; D000936:Antigen-Antibody Complex; D001324:Autoantigens; D016207:Cytokines; D004247:DNA
Blood. 2008 Dec 15;112(13):4991-8
18812467
Stem Cells Dev. 2004 Jun;13(3):263-71
15186722
Arthritis Rheum. 2007 Apr;56(4):1175-86
17393437
Clin Exp Allergy. 2001 May;31(5):678-85
11422126
Blood. 2008 Feb 1;111(3):1327-33
17951526
Blood. 2005 Apr 1;105(7):2821-7
15591115
J Immunol. 2009 Jul 15;183(2):993-1004
19561093
Scand J Immunol. 2007 Apr;65(4):336-43
17386024
Ann Neurol. 2007 Mar;61(3):219-27
17387730
Nature. 1997 Jul 10;388(6638):133-4
9217150
Cell Stem Cell. 2008 Feb 7;2(2):141-50
18371435
Trends Immunol. 2007 May;28(5):219-26
17400510
Blood. 2003 May 1;101(9):3722-9
12506037
Blood. 1995 Jan 15;85(2):487-94
7812003
Blood. 2005 Sep 1;106(5):1755-61
15905186
Int Rev Immunol. 1998;17(1-4):1-52
9914942
Eur J Immunol. 1991 Nov;21(11):2671-7
1936115
Blood. 2003 May 1;101(9):3568-73
12506012
J Immunol. 2002 Aug 1;169(3):1277-82
12133949
Eur J Immunol. 2001 Sep;31(9):2726-32
11536171
Cell Stem Cell. 2008 Jun 5;2(6):566-75
18522849
Blood. 2002 May 15;99(10):3838-43
11986244
Blood. 2007 Jan 1;109(1):228-34
16985180
Stem Cells. 2008 Feb;26(2):562-9
18024418
Transplantation. 2003 Oct 27;76(8):1208-13
14578755
Lupus. 2007;16(2):121-8
17402368
Stem Cells. 2006 Jan;24(1):74-85
16099998
Eur J Immunol. 2006 Oct;36(10):2566-73
17013987
Blood. 2005 May 15;105(10):4120-6
15692068
Eur J Immunol. 2005 May;35(5):1482-90
15827960
Blood. 2004 Mar 1;103(5):1662-8
14592819
Exp Hematol. 2002 Jan;30(1):42-8
11823036
Immunity. 1998 Mar;8(3):363-72
9529153
Blood. 2006 Jan 1;107(1):367-72
16141348
J Immunol. 2002 Oct 15;169(8):4213-21
12370351
J Immunol. 2007 Aug 1;179(3):1855-63
17641052
Science. 1999 Apr 2;284(5411):143-7
10102814
Immunol Res. 2008;41(1):79-86
18506645
J Immunol. 2009 May 15;182(10):5994-6002
19414750
Blood Rev. 2006 May;20(3):161-71
16364518
J Virol. 1995 Mar;69(3):1895-902
7853531
Adv Exp Med Biol. 1992;323:111-7
1283045
Transplantation. 2006 May 27;81(10):1390-7
16732175
Blood. 2005 Feb 15;105(4):1815-22
15494428
J Immunol. 2006 Aug 15;177(4):2080-7
16887966
J Immunol. 2003 Oct 1;171(7):3426-34
14500637
Diabetologia. 2009 Jul;52(7):1391-9
19421731
Nat Med. 2009 Jan;15(1):18-20
19129775
Nat Med. 2009 Jan;15(1):42-9
19098906
DNA Cell Biol. 2005 Jul;24(7):458-63
16008514
Haematologica. 2007 Sep;92(9):1208-15
17666368
Transplantation. 2003 Feb 15;75(3):389-97
12589164
J Immunol. 2003 Aug 15;171(4):1684-90
12902466
Cell Stem Cell. 2009 Mar 6;4(3):206-16
19265660
Leukemia. 2003 Jan;17(1):160-70
12529674
Blood. 2004 Jun 15;103(12):4619-21
15001472
Nat Rev Immunol. 2008 Sep;8(9):726-36
19172693
Blood. 2005 Mar 1;105(5):2214-9
15514012
Exp Hematol. 2001 Feb;29(2):244-55
11166464
Scand J Immunol. 2003 Jan;57(1):11-20
12542793